{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2002-N-0279\" sorted by posted_date descending", "rows": [["FDA-2002-N-0279-0027", "FDA", "FDA-2002-N-0279", "Tab 20 - [Reference (Drug Expenditure Tables)] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T22:02:41Z", null, 0, 0, "090000648049e6cc"], ["FDA-2002-N-0279-0016", "FDA", "FDA-2002-N-0279", "Tab 4 - [Reference (FDA to Lord, Bissell & Brook on Behalf of Apotex, Inc. Citizen Petition)] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:06Z", null, 0, 0, "090000648049e6c6"], ["FDA-2002-N-0279-0024", "FDA", "FDA-2002-N-0279", "Tab 14 - [Reference (Congressional Budget Office \"How Increased Competition from Generic Drugs has Affected Prices and Returns in the Pharmaceutical Industry\" (July 1998))] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:20Z", null, 0, 0, "090000648049e6c9"], ["FDA-2002-N-0279-0013", "FDA", "FDA-2002-N-0279", "Tab 1 - [Reference \"FTC Citizen Petiton\"] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:06Z", null, 0, 0, "090000648049e6bc"], ["FDA-2002-N-0279-0017", "FDA", "FDA-2002-N-0279", "Tab 5 - [Reference (Guidance for Industry \"Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients\")] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:06Z", null, 0, 0, "090000648049e6c7"], ["FDA-2002-N-0279-0019", "FDA", "FDA-2002-N-0279", "Tab 7 - [Reference Andrx Pharmaceuticals, Inc. v. Biovail Corporation International and Tommy Thompson, Secretary DHHS] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:07Z", null, 0, 0, "090000648049e6cd"], ["FDA-2002-N-0279-0022", "FDA", "FDA-2002-N-0279", "Tab 10 - [Reference \"The Patent Term Restoration Act of 1983\"] (page 48, 56 and 57  Lewis A. Engman Comment)] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:20Z", null, 0, 0, "090000648049e6c3"], ["FDA-2002-N-0279-0020", "FDA", "FDA-2002-N-0279", "Tab 8 - [Reference \"Congressional House\" (Page H 6916 thru H 6921 (9/13/1982))] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:19Z", null, 0, 0, "090000648049e6bf"], ["FDA-2002-N-0279-0012", "FDA", "FDA-2002-N-0279", "Reference Listing - [Tab 1 thru 19 Reference Title List] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:13:53Z", null, 0, 0, "090000648049e6bd"], ["FDA-2002-N-0279-0026", "FDA", "FDA-2002-N-0279", "Tab 19 - [Reference \"National Health Care Expenditures Projections: 2001-2011\" (Centers for Medicare & Medicaid Services - Office of the Actuary)] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T22:01:17Z", null, 0, 0, "090000648049e6cb"], ["FDA-2002-N-0279-0021", "FDA", "FDA-2002-N-0279", "Tab 9 - [Reference \"Congressional House\" (Page H 6922 thru H 6924 (9/13/1982))] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:20Z", null, 0, 0, "090000648049e6c1"], ["FDA-2002-N-0279-0014", "FDA", "FDA-2002-N-0279", "Tab 2 - [Reference \"Generic Drug Entry Prior to Patent Expiration\" (An FTC Study (July 2002))] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:57:55Z", null, 0, 0, "090000648049e6c0"], ["FDA-2002-N-0279-0015", "FDA", "FDA-2002-N-0279", "Tab 3 - [Reference (FDA to Biovail Laboratories Inc.)]  - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:06Z", null, 0, 0, "090000648049e6c4"], ["FDA-2002-N-0279-0018", "FDA", "FDA-2002-N-0279", "Tab 6 - [Reference (FDA to Beers, Korn, Arnold & Porter, McNichol, Scheineson, Frisch, Smith (Petiton Denial))] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:07Z", null, 0, 0, "090000648049e6c8"], ["FDA-2002-N-0279-0025", "FDA", "FDA-2002-N-0279", "Tab 16 - [Reference  \"The Pediatric Exclusivity Provision - January 2001 Status Report to Congress\" [DHHS/FDA]] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:49:03Z", null, 0, 0, "090000648049e6ca"], ["FDA-2002-N-0279-0023", "FDA", "FDA-2002-N-0279", "Tab 11 - [Reference (Mr. Kastenmeier Report from Judiciary Committee)] - Background Material", "Supporting & Related Material", "Reference (external attachments)", "2011-11-17T05:00:00Z", 2011, 11, null, null, "2011-11-17T21:14:20Z", null, 0, 0, "090000648049e6c5"], ["FDA-2002-N-0279-0011", "FDA", "FDA-2002-N-0279", "FDA [Technical Amendment] - Notice of Final Rule", "Notice", "NFR-Notice of Final Rule", "2004-03-15T05:00:00Z", 2004, 3, "2004-03-09T05:00:00Z", null, "2009-03-09T17:44:23Z", null, 0, 0, "090000648049e7bb"], ["FDA-2002-N-0279-0009", "FDA", "FDA-2002-N-0279", "Tab A - OMB Review (6/18/2000) [Final Rule page 1 thru 99] - Reference", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2003-11-06T05:00:00Z", 2003, 11, null, null, "2009-03-10T13:10:24Z", null, 0, 0, "090000648049e7b6"], ["FDA-2002-N-0279-0006", "FDA", "FDA-2002-N-0279", "Tab B - [OMB Review ([Notice of Final Rule page 99 thru 121 and FDA3542a) (6/18/2003)] - Reference", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2003-11-06T05:00:00Z", 2003, 11, null, null, "2009-03-10T13:13:07Z", null, 0, 0, "090000648049e7ae"], ["FDA-2002-N-0279-0010", "FDA", "FDA-2002-N-0279", "Cover Page - OMB Review (6/18/2003)  - Reference", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2003-11-06T05:00:00Z", 2003, 11, null, null, "2009-03-10T13:16:38Z", null, 0, 0, "090000648049e7b9"], ["FDA-2002-N-0279-0007", "FDA", "FDA-2002-N-0279", "Tab B - [OMB Review ([Notice of Final Rule page 1 thru 98)  (6/18/2003)] - Reference", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2003-11-06T05:00:00Z", 2003, 11, null, null, "2009-03-10T13:01:39Z", null, 0, 0, "090000648049e7b1"], ["FDA-2002-N-0279-0008", "FDA", "FDA-2002-N-0279", "OMB Review [Notice of Final Rule 100 thru 122  pages] (6/18/2003) - Reference", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2003-11-06T05:00:00Z", 2003, 11, null, null, "2009-03-09T18:15:49Z", null, 0, 0, "090000648049e7b4"], ["FDA-2002-N-0279-0005", "FDA", "FDA-2002-N-0279", "OMB INFORMATION COLLECTION - SUPPORTING STATEMENT", "Supporting & Related Material", "SS-Supporting Statement", "2003-08-12T04:00:00Z", 2003, 8, null, null, "2009-03-15T16:03:53Z", null, 0, 0, "090000648049e7ac"], ["FDA-2002-N-0279-0003", "FDA", "FDA-2002-N-0279", "FDA - Notice of Approval", "Notice", "NAL-Notice of Approval", "2003-08-12T04:00:00Z", 2003, 8, "2003-08-07T04:00:00Z", null, "2009-03-09T17:43:31Z", null, 0, 0, "090000648049e7a9"], ["FDA-2002-N-0279-0004", "FDA", "FDA-2002-N-0279", "OMB INFORMATION COLLECTION - SUPPORTING STATEMENT", "Supporting & Related Material", "SS-Supporting Statement", "2003-08-12T04:00:00Z", 2003, 8, null, null, "2009-03-15T16:03:11Z", null, 0, 0, "090000648049e7aa"], ["FDA-2002-N-0279-0002", "FDA", "FDA-2002-N-0279", "FDA - Notice of Final Rule", "Notice", "NFR-Notice of Final Rule", "2003-07-01T04:00:00Z", 2003, 7, "2003-06-12T04:00:00Z", null, "2009-03-09T17:42:58Z", null, 0, 0, "090000648049e7a5"], ["FDA-2002-N-0279-0001", "FDA", "FDA-2002-N-0279", "FDA - Notice of Proposed Rule-Making", "Notice", "NPR-Notice of Proposed Rule-Making", "2002-10-28T05:00:00Z", 2002, 10, "2002-10-28T05:00:00Z", "2002-12-24T04:59:59Z", "2009-03-09T17:41:56Z", null, 0, 0, "090000648049e6ba"]], "truncated": false, "filtered_table_rows_count": 27, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2002-N-0279"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2002-N-0279", "results": [{"value": "FDA", "label": "FDA", "count": 27, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2002-N-0279", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 23, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2002-N-0279", "results": [{"value": 2011, "label": 2011, "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&posted_year=2011", "selected": false}, {"value": 2003, "label": 2003, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&posted_year=2003", "selected": false}, {"value": 2002, "label": 2002, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&posted_year=2002", "selected": false}, {"value": 2004, "label": 2004, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&posted_year=2004", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&_facet=posted_month"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2002-N-0279&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 2782.8115089796484, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}